PIONEERING PROTEINS TO CONQUER CANCER

Developing protein therapeutics to transform patient outcomes with disruptive technology. 

Our Mission

xCella is developing best-in-class protein therapeutics as game-changing cancer treatments. Our proprietary xEmplar human antibody library and disruptive xPloration screening technology, combined with our team’s deep expertise in protein engineering and cancer biology, are enabling rapid discovery and development of next-generation therapies for cancer patients. 

We are building a pipeline of protein therapeutics against emerging oncology targets, including XC-201, a unique clinic ready asset that directs T cell mediated immunotherapy to a broad range of tumors.

Our Technologies

Innovative technologies paired with world-class talent accelerate discovery of efficacious antibodies.